Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Verastem, Inc. (VSTM)  
$13.16 1.14 (9.48%) as of 4:30 Tue 5/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 25,230,000
Market Cap: 332.03(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.8 - $14.07
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Verastem is a late stage development biopharmaceutical company, with ongoing registration directed trials, focused on developing and commercializing medicines for patients battling cancer. Co.'s product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors. VS-6766 is an orally available small molecule rapidly accelerated fibrosarcoma/ mitogen-activated protein kinase kinase clamp. Defactinib is an oral small molecule inhibitor of Focal Adhesion Kinase and proline-rich tyrosine kinase that is being evaluated as a potential combination therapy for various solid tumors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 1,735 21,833 25,311 165,018
Total Sell Value $18,442 $258,319 $292,764 $385,800
Total People Sold 4 4 4 4
Total Sell Transactions 9 20 37 63
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 268
  Page 9 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Aldrich Richard Director   –       •       •   2013-07-15 4 AB $17.19 $17,190 I/I 1,000 3,000     -
   Aldrich Richard Director   –       •       •   2013-07-08 4 AB $14.69 $14,690 I/I 1,000 2,000     -
   Westphal Christoph H Director   –       •       •   2013-07-01 4 D $13.88 $82,211 D/D (5,923) 701,166     -
   Aldrich Richard Director   –       •       •   2013-07-01 4 AB $14.11 $14,110 I/I 1,000 1,000     -
   Forrester Robert President and COO   •       –      –    2013-06-13 4 B $11.39 $11,394 D/D 1,000 254,974 2.74     -
   Chp Iii Lp 10% Owner   –       –       •   2013-06-12 4 B $9.60 $222,425 D/D 23,171 2,329,121 2.45     -
   Phanstiel S. Louise Director   –       •      –    2013-06-12 4 B $9.60 $43,202 I/I 4,500 16,500 2.1     -
   Termeer Henri A Director   –       •      –    2013-06-12 4 B $9.74 $56,741 D/D 5,823 17,179 2.39     -
   Clarke John K Director   –       •      –    2013-06-12 4 B $9.60 $222,425 I/I 23,171 2,329,121 2.1     -
   Chp Iii Lp 10% Owner   –       –       •   2013-06-11 4 B $9.22 $230,477 D/D 25,000 2,305,950 2.45     -
   Phanstiel S. Louise Director   –       •      –    2013-06-11 4 B $9.37 $74,978 I/I 8,000 12,000 2.1     -
   Clarke John K Director   –       •      –    2013-06-11 4 B $9.22 $230,477 I/I 25,000 2,305,950 2.1     -
   Termeer Henri A Director   –       •      –    2013-06-11 4 B $9.35 $106,221 D/D 11,356 11,356 2.39     -
   Phanstiel S. Louise Director   –       •      –    2013-06-10 4 B $9.16 $36,650 I/I 4,000 4,000 2.1     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-06-07 4 AB $9.06 $9,056 D/D 1,000 707,089     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-05-30 4 A $9.40 $7,525 D/D 800 706,089     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-05-21 4 AB $9.24 $7,393 D/D 800 705,289     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-05-13 4 A $9.70 $7,828 D/D 800 704,489     -
   Clarke John K Director   –       •      –    2013-05-13 4 AB $9.74 $243,375 I/I 25,000 2,280,950     -
   Chp Iii Lp 10% Owner   –       –       •   2013-05-13 4 AB $9.74 $243,375 D/D 25,000 2,280,950     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-05-03 4 AB $9.83 $7,862 D/D 800 703,689     -
   Clarke John K Director   –       •      –    2013-05-01 4 AB $9.66 $96,622 I/I 10,000 2,255,950     -
   Chp Iii Lp 10% Owner   –       –       •   2013-05-01 4 AB $9.66 $96,620 D/D 10,000 2,255,950     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-04-25 4 A $9.89 $7,917 D/D 800 702,889     -
   Clarke John K Director   –       •      –    2013-04-17 4 B $9.50 $53,489 I/I 5,631 2,245,950 2.1     -
  268 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us